GSK's Preemption Argument Fails To Stop Paxil Case
A judge has rebuffed GlaxoSmithKline PLC's federal preemption arguments, giving the go-ahead to a product liability lawsuit alleging that the drugmaker's antidepressant Paxil caused a man to attempt suicide....To view the full article, register now.
Already a subscriber? Click here to view full article